368441-44-5

Basic information

• Product Name: 2-tert-butyl 5-methyl isoindoline-2,5-dicarboxylate
• Synonyms: 2-tert-butyl 5-methyl isoindoline-2,5-dicarboxylate;1,3-Dihydro-2H-isoindole-2,5-dicarboxylic acid 2-(tert-butyl) 5-methyl ester;N-(tert-Butoxycarbonyl)-5-(methoxycarbonyl)isoindoline;2-(tert-butoxycarbonyl)-1-methylisoindoline-5-carboxylate;2H-Isoindole-2,5-dicarboxylic acid, 1,3-dihydro-, 2-(1,1-dimethylethyl) 5-methyl ester;TERT-BUTYL METHYL ISOINDOLINE-2,5-DICARBOXYLATE
• CAS NO: 368441-44-5
• Molecular Formula: C15H19NO4
• Molecular Weight: 277
• Mol File: 368441-44-5.mol
• Article Data: 8

Chemical Properties

• Appearance: /
• Density: 1.181
• CAS DataBase Reference: 2-tert-butyl 5-methyl isoindoline-2,5-dicarboxylate(CAS DataBase Reference)
• NIST Chemistry Reference: 2-tert-butyl 5-methyl isoindoline-2,5-dicarboxylate(368441-44-5)
• EPA Substance Registry System: 2-tert-butyl 5-methyl isoindoline-2,5-dicarboxylate(368441-44-5)

Safety Data

• Hazardous Substances Data: 368441-44-5(Hazardous Substances Data)

Usage

General Description

2-tert-butyl 5-methyl isoindoline-2,5-dicarboxylate is a chemical compound with the molecular formula C15H21NO4. It is a tertiary butyl ester of isoindoline-2,5-dicarboxylic acid and is commonly used as an intermediate in the synthesis of pharmaceuticals and agrochemicals. 2-tert-butyl 5-methyl isoindoline-2,5-dicarboxylate is known for its potential as a bioactive molecule, showing promise in the development of new drugs. It has also been studied for its anti-inflammatory and antioxidant properties. Additionally, it is used as a building block in the synthesis of various organic compounds and can be utilized in organic reactions for the preparation of new chemical entities.

Upstream product

• 201940-08-1 5-bromo-1,3-dihydro-isoindole-2-carboxylic acid tert-butyl ester 
• 127168-94-9 methyl 2,3-dihydro-2-(phenylmethyl)-1H-isoindole-5-carboxylate 
• 691-64-5 di-tert-butyl oxalate 
• 201230-82-2 carbon monoxide 
• 67-56-1 methanol 
• 6941-75-9 5-Bromoisoindoline-1,3-dione 
• 3375-31-3 palladium diacetate 
• 24424-99-5 di-tert-butyl dicarbonate 
• 127168-84-7 5-bromoisoindoline 
• 86-90-8 4-bromophthalic anhydride 

Downstream Products

• 149353-71-9 2-(tert-butoxycarbonyl)isoindoline-5-carboxylic acid 
• 742666-57-5 methyl isoindoline-5-carboxylate 
• 253801-14-8 tert-butyl 5-(hydroxymethyl)-1,3-dihydro-2H-isoindole-2-carboxylate 
• 685565-60-0 N-[4-(3-piperidin-1-ylpropoxy)benzoyl]-5-cyanoisoindoline 
• 263888-56-8 tert-butyl 5-cyanoisoindoline-2-carboxylate 
• 253801-15-9 5-formyl-1,2-dihydro-isoindole-2-carboxylic acid tertiary butyl ester 

Relevant articles and documents

ISOINDOLINE DERIVATIVES WHICH BIND TO AN ATP BINDING SITE

The present invention relates to novel probe compounds of formulae I and II defined herein. The present invention also relates to methods of synthesising these novel probe compounds and to their use in assays and screens for determining the binding of a test molecule to the ATP-binding site of a target protein, such as, for example, the Mismatch Repair (MMR) component proteins PMS2 and MLH1, or for determining the location and/or quantity of such target proteins in a biological sample.

Benzenesulfonyl-Asymmetric Ureas and Medical Uses Thereof

Benzenesulfonyl-asymmetric ureas are provided for the treatment of conditions modulated by the ghrelin receptor.

HETERO-HALO INHIBITORS OF HISTONE DEACETYLASE

This invention provides compounds that are inhibitors of HDAC2. The compounds (e.g., compounds according to Formula I, II or any of Compounds 100-128 or any of those in Tables 2 or 3) accordingly are useful for treating, alleviating, or preventing a condition in a subject such as a neurological disorder, memory or cognitive function disorder or impairment, extinction learning disorder, fungal disease or infection, inflammatory disease, hematological disease, or neoplastic disease, or for improving memory or treating, alleviating, or preventing memory loss or impairment.